BPI Labs LLC
FDA 503B outsourcing facility
Largo, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2019
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: April 17, 2026
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- March 4, 2019
- Most recent registration
- December 3, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- April 17, 2026
The FDA last inspected BPI Labs LLC on April 17, 2026. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
What this facility compounds
BPI Labs LLC reports compounding 3 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Semaglutide, Tirzepatide.
- Semaglutide
- Testosterone Cypionate
- Tirzepatide
Location
12393 S Belcher Rd, Largo, FL 33773
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Supriya Taneja, 1-727-471-0850. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of BPI Labs LLC with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is BPI Labs LLC registered with the FDA?
Yes. BPI Labs LLC is a registered 503B outsourcing facility, first registered with the FDA on March 4, 2019 and most recently registered on December 3, 2025.
Has BPI Labs LLC been inspected by the FDA?
The FDA last inspected BPI Labs LLC on April 17, 2026. A Form FDA 483 was issued.
Has BPI Labs LLC had any FDA drug recalls?
No FDA drug recalls are matched to BPI Labs LLC in the openFDA enforcement database.
What does BPI Labs LLC compound?
BPI Labs LLC reports compounding 3 active ingredients to the FDA, including Semaglutide, Tirzepatide.
Where is BPI Labs LLC located?
BPI Labs LLC is located in Largo, Florida (12393 S Belcher Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by BPI Labs LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.